ARCHIVES

New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor.

This article is from The Cancer Letter archive.

Vol. 32 No. 07 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

Clinton Proposes $1.15 Billion Increase For NIH; Support For Cancer Research

January 30, 1998

Carter Accepts Upton’s Resignation Effective Dec. 31; DeVita Acting Director; Search Committee Formed

December 7, 1979

Authorizes $2.7 Billion For NCI, 7% Prevention

May 28, 1993

NCI Facing Extended Tie Under Acting Director – Maybe

August 19, 1988

Senate Subcommittee Oks $850Million for Cancer; NCI Reveals How It Would Spend Fiscal 1978 Funds

June 18, 1976

NCI To Fund More SPORE Grants In FY95 Recopetition

March 11, 1994